23 articles for MP Wentland
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
24
Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8- difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarb oxylic acid and related derivatives.

Sterling Winthrop Pharmaceuticals Research Division
4
Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative.

Sterling-Winthrop Research Institute
17
Synthesis and antidepressant properties of novel 2-substituted 4,5-dihydro-1H-imidazole derivatives.

TBA
9
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 9: Synthesis, characterization and molecular modeling of pyridinyl isosteres of N-BPE-8-CAC (1), a high affinity ligand for opioid receptors.

Rensselaer Polytechnic Institute
24
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 8. High affinity ligands for opioid receptors in the picomolar Ki range: oxygenated N-(2-[1,1'-biphenyl]-4-ylethyl) analogues of 8-CAC.

Rensselaer Polytechnic Institute
22
Syntheses of novel high affinity ligands for opioid receptors.

Rensselaer Polytechnic Institute
41
Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.

Rensselaer Polytechnic Institute
20
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine.

Rensselaer Polytechnic Institute
21
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4'-phenyl)-phenethyl) analogues of 8-CAC.

Institute
17
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.

Rensselaer Polytechnic Institute
6
Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone.

Rensselaer Polytechnic Institute
9
Selective protection and functionalization of morphine: synthesis and opioid receptor binding properties of 3-amino-3-desoxymorphine derivatives.

Rensselaer Polytechnic Institute
8
3-Carboxamido analogues of morphine and naltrexone. synthesis and opioid receptor binding properties.

Pharmacia
16
8-Aminocyclazocine analogues: synthesis and structure-activity relationships.

Institute
23
The antitumor activity of novel pyrazoloquinoline derivatives

TBA
7
Arylacetamide kappa-selective opioid ligands

TBA
11
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: syntheses and opioid receptor properties of cyclic variants of cyclazocine.

Rensselaer Polytechnic Institute
37
10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors.

Harvard Medical School
16
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues.

Rensselaer Polytechnic Institute
43
Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines.

Rensselaer Polytechnic Institute
14
8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines.

Rensselaer Polytechnic Institute
24
Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives.

Sanofi Winthrop
15
Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: exploration of 6-6 fused rings as alternative S1 moieties.

Daiichi Sankyo